First, we found that concurrent activation of oncogenic and tumor suppressive effects underlie altruistic fitness benefits and cost respectively, and this was orchestrated by a single regulator RNA, miR-125b, via the involvement of different parts of the NF-κB signaling pathway (Fig. 5B). The gene discussed is NFKB1; the disease is neoplasm.